When is it recommended to remove a nephrostomy (percutaneous nephrostomy tube) in a patient with a history of kidney disease or cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nephrostomy Tube Removal Timing and Indications

For most patients undergoing percutaneous nephrolithotomy (PCNL), nephrostomy tubes should be removed within 24-48 hours for complex stones, while uncomplicated cases may not require tube placement at all. 1

Standard Removal Timeline

Complex Stone Disease

  • Complex stones require nephrostomy tube drainage for at least 24-48 hours to ensure adequate hemostasis and drainage 1
  • Post-procedure management varies by case complexity: immediate removal for simple cases, 24-48 hours for moderate complexity, and 5-7 days for highly complex situations 1
  • The decision depends on intraoperative findings including residual stone burden, collecting system perforation, and bleeding 2

Uncomplicated Cases

  • In patients undergoing uncomplicated PCNL who are presumed stone-free, nephrostomy tube placement is optional 1
  • Tubeless PCNL is safe and efficacious for uneventful procedures, demonstrating less pain, shorter hospital stays, and comparable complication rates to standard PCNL 3
  • Mean stone-free rates for tubeless PCNL reach as high as 89% 3

Specific Indications to Maintain Nephrostomy Tube

Absolute Indications for Prolonged Drainage

  • More than 2 nephrostomy access tracts require continued tube placement 3
  • Significant intraoperative bleeding necessitates tract tamponade with the nephrostomy tube 3
  • Collecting system perforation requires drainage for healing 3
  • Gross residual stone burden when second-look nephroscopy is planned 4
  • Active infection with purulent urine requires establishment of drainage with broad-spectrum antibiotics 1

Relative Indications

  • Difficult anatomy or challenging access may warrant reentry Malecot catheters (20F) for 5-7 days 4
  • Infection stones (struvite) more commonly require larger bore tubes (57.1% vs 12.0% for non-struvite stones) 4
  • Multiple simultaneous accesses may benefit from circle loop catheters 4

Post-Removal Expectations

Normal Healing Timeline

  • Complete healing of the nephrostomy tract typically occurs within 1-2 weeks after tube removal 5
  • Frequent urination is normal as the urinary system adjusts 5
  • Mild hematuria occurs in approximately 50% of patients after PCN and is clinically asymptomatic 5, 1

Urinary Leak Management

  • Smaller pigtail catheters (9F) significantly reduce the duration of urinary leak compared to large-bore tubes (28F) 6
  • The duration of urinary leak is statistically shorter with smaller tubes, reducing hospital stay 6

When Tube Replacement is Necessary

Urgent Replacement Indications

Immediate assessment is essential if accidental removal occurs, with urgent replacement indicated for: 5

  • Active infection with obstruction
  • Bilateral obstruction
  • Solitary kidney with obstruction
  • Percutaneous nephrostomy replacement has technical success rates approaching 100% 5

Common Pitfalls to Avoid

Technical Considerations

  • Never lose access to an obstructed kidney once punctured - placement of a "safety" wire for all complex manipulations is recommended 7
  • Avoid unnecessary prolonged procedures in an infected, obstructed system to minimize sepsis risk 7
  • Always use self-retaining drainage catheters to minimize inadvertent dislodgment 7

Bleeding Management

  • Excessive bleeding usually can be stopped with tract tamponade using a balloon catheter or appropriate-sized nephrostomy tube 7
  • Persistent bleeding requires arteriographic evaluation, with most cases treatable by transcatheter embolization 1, 7
  • Clinically significant bleeding occurs in less than 1-4% of cases, with most settling with prolonged tube drainage alone 1

Infection Prevention

  • Antibiotics should be administered routinely before nephrostomy drainage based on patient-specific risk factors for bacteriuria 7
  • For fungal UTIs, perform irrigation with amphotericin B deoxycholate in conjunction with systemic therapy, and consider tube removal or replacement if feasible 1

References

Related Questions

What is the duration that nephrostomy (percutaneous renal catheter) tubes can remain in place?
Can a patient retain nephrostomy (percutaneous catheter) tubes?
Can the patient follow up with the nephrologist after nephrostomy tube removal?
Does the patient need to remain NPO (nil per os) after a pigtail (percutaneous) catheter placement?
Is it appropriate to flush a nephrostomy tube?
Can Paxlovid (nirmatrelvir and ritonavir) increase blood pressure in patients, particularly those with pre-existing hypertension or cardiovascular disease?
What's the next step for a type 2 diabetes patient on 20 units of Lantus (insulin glargine) with an elevated Hemoglobin A1C (HbA1c) level, persistent hyperglycemia, and recently added Ozempic (semaglutide), considering adding Novolog (insulin aspart)?
What is the best course of action for an elderly female patient with significant narrowing and enhancement within the distal common bile duct (CBD), substantial upstream biliary dilatation, moderate main pancreatic duct dilatation, and a cyst in the pancreatic head?
What is the best course of action for an adult patient with a history of bipolar disorder, depression, and anxiety, currently experiencing symptoms of depression, fatigue, and anxiety while taking Cymbalta (duloxetine) 30mg and Vraylar (cariprazine) 1.5mg?
What treatment options are available for a patient experiencing weight gain due to Abilify (aripiprazole)?
Can meropenem and daptomycin be given together to a patient with end-stage renal disease (Impaired renal function) on dialysis, with a history of toe amputation, and growing Enterobacter cloacae and Vancomycin-resistant Enterococcus (VRE)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.